The COVID-19 pandemic has significantly impacted the Japanese large-joint reconstructive implant market, as hip and knee replacement procedures are delayed and unit sales decline. While the crisis will significantly impact the market in the short-term, other factors will continue to drive market growth. Through 2029, the Japanese market for large-joint reconstructive implants will grow modestly, with favorable demographic factors supporting procedure volumes. However, downward pricing pressures driven by falling biennial MHLW reimbursement cuts and price competition will partially offset the impact of procedural expansion on overall market revenues.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for large-joint reconstructive implants in Japan across a 10-year period.
The emergence of COVID-19 is affecting the large-joint reconstructive implant market in the short term.
How will COVID-19 affect procedure volumes in the Japanese large-joint reconstructive implant market?
What will be the impact on market dynamics and what strategies can companies use to remain successful in this market?
In spite of the complicated regulatory environment, some competitors possess advantages due to their knowledge of the domestic marketplace or can leverage their success in other markets.
Which competitors are best poised for success going forward?
How does the regulatory system affect current and future market revenues for companies in this space?
Biennial MHLW reimbursement cuts will continue to negatively affect the Japanese large-joint reconstructive implant market.
Which segments will be most severely impacted by the MHLW reimbursement cuts?
To what degree will reimbursement cuts be compounded by market competition?
Given recent regulatory approvals for partial and total knee arthroplasty applications, orthopedic surgical robotic platforms are poised to see increasing adoption and growing use in joint reconstruction procedures in Japan.
Which implant manufacturers are best positioned to capitalize on growing uptake of robotic-assisted joint reconstruction?
How will advances in large-joint reconstructive implant surgical techniques impact the Japanese market?
- Large-Joint Reconstructive Implants - Market Insights - Japan
Author(s): Meenu Sankar, MS
Meenu Sankar is an analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in large-joint reconstructive implants. Meenu holds a Bachelor's degree in Pharmaceutical Sciences from Manipal University and a Master's degree in Biomedicine from The University of Skövde.
Follow Meenu on Twitter:@meenu_sankarDRG